AI assistant
GERON CORP — Director's Dealing 2010
Jul 13, 2010
32370_dirs_2010-07-13_8f03ed2d-f849-4d79-93e7-ea880451342d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GERON CORP (GERN)
CIK: 0000886744
Period of Report: 2010-07-09
Reporting Person: Spink Katharine E. (VP Operations, Regen Med Progs)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-07-09 | Common Stock | A | 10000 | — | Acquired | 101571 | Direct |
| 2010-07-09 | Common Stock | A | 90000 | — | Acquired | 191571 | Direct |
| 2010-07-09 | Common Stock | A | 35000 | — | Acquired | 226571 | Direct |
| 2010-07-09 | Common Stock | A | 90000 | — | Acquired | 316571 | Direct |
Footnotes
F1: The shares of restricted stock will remain subject to a reacquisition right of Geron over three years until the achievement of certain performance milestone criteria in connection with the Company's imetelstat program.
F2: The shares of restricted stock will remain subject to a reacquisition right of Geron over three years until the achievement of certain performance milestone criteria in connection with the Company's GRNOPC1 program.
F3: The shares of restricted stock will remain subject to a reacquisition right of Geron over three years until the achievement of certain performance milestone criteria in connection with the Company's strategic initiatives.
F4: The shares of restricted stock will remain subject to a reacquisition right of Geron over three years until the Company's common stock price exceeds certain thresholds.